OVA1™ test for the assessment of suspected ovarian cancer

OVA1™ test for the assessment of suspected ovarian cancer

February 2011
Technology Description:

BESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswy

The OVA1™ test is a blood test that measures the serum levels of 5 biomarkers and indicates the risk that a woman with symptoms may have ovarian cancer. It is intended to provide an additional option for the pre-operative assessment of women in whom a potentially cancerous lump has been detected on their ovaries or fallopian tubes.